Neuropace
NPCE
trading on NASDAQ
since 2021
$12.85
(Δ -2.95%)
-$0.39 since open
Neuropace is a medical technology company that develops and manufactures advanced neural monitoring systems for use in neurosurgical procedures.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $13.07 | $13.22 | $12.43 | $415.23M | 195.38K |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.21 | n/a | 17.96 | -22.85% | -29.25% | 0% |